© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Norfloxacin nicotinate stands as a derivative of Norfloxacin, a fluoroquinolone antibiotic, combined with nicotinic acid. This combination produces a compound sought in chemical, pharmaceutical, and research fields for its studied properties and mechanisms. Born from innovations in antibacterial therapy, Norfloxacin nicotinate typically appears as a white to pale yellow solid, often described as crystalline powder or crystalline flakes. Known for its high purity, stable structure, and defined characteristics, it holds a unique position among raw materials used in the synthesis and formulation of medication.
The substance bears the molecular formula C17H17FN4O5. By calculation, the molecular weight reaches 376.34 g/mol. This compound demonstrates a stable crystalline structure; one finds it most often supplied as solid powder, but it can also form flakes or crystals depending on handling and preparation. In laboratory containers, its density registers at roughly 1.6 g/cm³—a measurable property when classifying chemicals for safe storage and use. On a technical sheet, one would read a melting point above 210°C, a feature useful for quality checks or research involving thermal stability.
Chemical manufacturers describe Norfloxacin nicotinate as a fine, tasteless, almost odorless material—easy to distinguish from impure batches or substitutions. Research-grade product should carry a certificate of analysis proving it meets purity thresholds, usually upwards of 98%. Insoluble in water, it dissolves better in ethanol or dilute acids, presenting the flexibility needed in certain pharmaceutical processes. The appearance as a fine powder, dense flakes, or glimmering crystals reflects proper crystallization procedures during production. Each form influences how the raw material integrates into mixtures or solutions—important for pharmaceutical compounding or reformulation. The compound responds in predictable ways to standard chemical tests for identification, such as IR and NMR spectra matching industry expectations.
Norfloxacin nicotinate enters various formulations for research and product development. Its primary value appears in drug development pipelines, where pharmaceutical scientists look for targeted antibiotic activity combined with different absorption properties thanks to the nicotinate component. In industrial applications, product traceability hinges on unique identifiers. Customs and logistics teams rely on its HS Code, which for this material often falls under 29334900—an international trade identifier that eases import and export between chemical suppliers and end-users. In addition to its pharmaceutical profile, the pure product sometimes becomes a topic in academic research exploring new ways to bond fluoroquinolones or improve antimicrobial spectra. Every successful batch needs documentation of origin, batch, and quality control to meet regulations for both worker safety and environmental protection.
Working near Norfloxacin nicotinate, safety comes first. This compound rates as a hazardous material—meaning it can cause harm if inhaled, ingested, or absorbed through the skin during handling. Chemical safety protocols require gloves, masks, eye protection, and proper fume hoods for weighing and processing. Disposal procedures should include containment for residues and containers, alerting local authorities if a spill of significant quantity occurs. As with many raw antibiotic materials, environmental stewardship matters. Improper disposal could contribute to microbially-active waste that threatens local waterways or promotes antibiotic resistance, an escalating global concern. Manufacturers must adopt rigorous waste management, labeling, and spill control plans. Storage should involve cool, dry locations away from incompatible chemicals or acids, securing the raw material from unauthorized access or accidental mixing. Workers benefit from ongoing training and clear hazard communication.
Laboratories and pharmaceutical production lines depend on authentic, clearly-sourced Norfloxacin nicotinate. Seeking reputable suppliers reduces risk of contamination or substitution. Every batch needs to carry verifiable certificates outlining lot number, purity, specifications, manufacturing history, and compliance with industry standards. Unlabeled or misclassified material can introduce costly errors and jeopardize end products. I have seen how sourcing from partners with poor transparency undercuts trust, delays projects, and even brings regulatory scrutiny. Strong supplier relationships, routine testing, and external audits bridge the gap between lab requirements and material purity. In making antibiotics or research reagents, shortcutting these steps introduces the chance for failure or harm.
For all its technical and chemical complexity, Norfloxacin nicotinate remains one of countless raw materials shaping current medical research. Its distinct blend of norfloxacin’s antimicrobial reach and nicotinate’s altered pharmacological profile sparks hope for new therapies—assuming responsible manufacture, handling, and use. By respecting material safety data, enforcing best practices for storage, and working with thorough, transparent suppliers, everyone from research chemist to warehouse team contributes to supply chain integrity and end-user safety. New compounds bring risk and promise in equal measure; focus on physical and chemical essentials grounds progress in real-world safety, scientific rigor, and human health.
